Will modern miniaturized left ventricular assist devices offer a viable alternative to heart transplantation?

Hellenic Journal of Cardiology

Volumn 49, Issue 5, 2008, Pages 335-348

  Visouli, Aikaterini N ^a   Pitsis, Antonis A ^a,b  

^a St Luke's Hospital   (Greece)

^b St Luke s Hospital   (Greece)

Author keywords

Heart transplantation; Long term mechanical circulatory support; Ventricular assist device (VAD)

Indexed keywords

ASSISTED CIRCULATION; BLOOD FLOW; BLOOD PRESSURE; CLINICAL TRIAL; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LUNG VASCULAR RESISTANCE; PATIENT ASSESSMENT; REVIEW;

EID: 57349089160     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Stevenson LW, Kormos RL, Bourge RC, et al. Mechanical cardiac support 2000: current applications and future trial design. J Am Coll Cardiol. 2001; 37: 340-370.
2. Kirklin JK. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Report. International Society of Heart and Lung Transplantation [Internet]. April 25-28, 2007 [cited 2008 May14]. Available from http://www.intermacs.org (Presentations).
3. Jessup M, Stevenson LW, Desvigne-Nickens P, et al. Patients with mechanical circulatory support (MCS): Is implant strategy static or dynamic? International Society of Heart and Lung Transplantation [Internet]. April 8-12, 2008 [cited 2008 May 12]. Available from http://www.intermacs.org (Presentations).
4. Felker GM, Rogers JG. Same bridge new destinations. J Am Coll Cardiol. 2006; 47: 930-932.
5. Young JB, Rogers JG, Portner PM, et al. Bridge to eligibility: LVAS support in patients with relative contraindications to transplantation. J Heart Lung Transplant. 2005; 24: S75.
6. INTERMACS, (Interagency Registry for Mechanically Assisted Circulatory Support), Quarterly Statistical Report, Implant Dates March 1, 2006 - November 30, 2007 [Internet] [cited 2008 March 12]. Available from http://www.intermacs. org
7. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007; 116: 497-505.
8. Stone ME. Current status of mechanical circulatory assistance. Semin Cardiothorac Vasc Anesth. 2007; 11: 185-204.
9. Stevenson LW, Couper G. On the fledgling field of mechanical circulatory support. J Am Coll Cardiol. 2007; 50: 748-751.
10. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001; 345: 1435-1443.
11. Stevenson LW, Miller LW, Desvigne-Nickens P, et al; for the REMATCH Investigators. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy. A subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation. 2004; 110: 975-981.
12. Dembitsky WP, Tector AJ, Park S, et al. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH Trial. Ann Thorac Surg. 2004; 78: 2123-2129.
13. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates. J Am Coll Cardiol. 2007; 50: 741-747.
14. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). Quarterly Statistical Summary Report March 2008 [Internet] [cited 2008 May 11]. Available from http://www.intermacs.org
15. Stevenson LW, Shekar P. Ventricular assist devices for durable support. Circulation. 2005; 112: e111-e115.
16. Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg. 2003; 75: S29-S35.
17. Miller LW, Pagani FD, Russell DS, et al. Use of a continuous-flow device in patients awaiting heart transplantation. New Engl J Med. 2007; 357: 885-896.
18. Feller ED, Sorensen EN, Haddad M, et al. Device selection clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients. Ann Thorac Surg. 2007; 83: 1082-1088.
19. Mudge GH Jr, Fang JC, Smith C, Couper G. The physiologic basis for the management of ventricular assist devices. Clin Cardiol. 2006; 29: 285-289.
20. Chumnanvej S, Wood MJ, MacGillivray TE, Melo MF. Perioperative echocardiographic examination for ventricular assist device implantation Anesth Analg. 2007; 105: 583-660.
21. Pitsis AA, Anagnostopoulos CE. Acute heart failure. is there a role for surgery? Heart Fail Rev. 2007; 12: 173-178.
22. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg. 2004; 77: 133-142.
23. Koster A, Loebe M, Hansen R, et al. Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD. Ann Thorac Surg. 2000; 70: 533-537.
24. Noon GP, Morley DL, Irwin S, et al. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg. 2001; 71: S133-S138.
25. Haj-Yahia S, Birks EJ, Rogers P. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg. 2007; 134: 199-203.
26. Selzman CH. Off-pump insertion of the Jarvik 2000 left ventricular assist device. Cardiothoracic Surgery Network [Internet]. 2008 [cited 2008 April 29]. Available from http://www.ctsnet.org/sections/clinicalresources/adultcardiac/ expert_tech-25.html
27. Potapov EV, Koster A, Loebe M, et al. The MicroMed DeBakey VAD - part I: The pump and the blood flow. J Extra Corpor Technol. 2003; 35: 274-283.
28. Frazier OH, Delgado RM, Kar B, et al. First clinical use of the redesigned HeartMate® II left ventricular assist system in the United States. Tex Heart Inst J. 2004; 31: 157-159.
29. Padalino MA, Ohye RG, Chang AC, Gajarski RJ, Bove EL, Devaney EJ. Bridge to transplant using the MicroMed DeBakey ventricular assist device in a child with idiopathic dilated cardiomyopathy. Ann Thorac Surg. 2006; 81: 1118-1121.
30. Delgado R, Bergheim M. HeartMate II left ventricular assist device: a new device for advanced heart failure. Expert Rev Med Devices. 2005; 2: 529-532.
31. Griffith BP, Kormos RL, Borovetz HS, et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg. 2001; 71 (3 Suppl): S116-120.
32. Frazier OH, Myers TJ, Gregoric ID, et al. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation. 2002; 105: 2855-2860.
33. Goldstein DJ. Worldwide experience with the MicroMed DeBakey ventricular assist device® as a bridge to transplantation. Circulation. 2003; 108 Suppl 1: II272-277.
34. Westaby S, Banning AP, Saito S, et al. Circulatory support for long-term treatment of heart failure. Experience with an intraventricular continuous flow pump. Circulation. 2002; 105: 2588-2591.
35. Siegenthaler MP, Martin J, Pernice K, et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg. 2003; 23: 748-755.
36. Myers TJ, Frazier OH, Mesina HS, Radovancevic B, Gregoric ID. Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant. 2006; 25: 379-383.
37. Siegenthaler MP, Martin J, Gutwald R, et al. Anterior approach to implant the Jarvik 2000 with retroauricular power supply. Ann Thorac Surg. 2005; 80: 745-747.
38. Anyanwu AC, Fischer GW, Plotkina I, Pinney S, Adams DH. Off-pump implant of the Jarvik 2000 ventricular assist device through median sternotomy. Ann Thorac Surg. 2007; 84: 1405-1407.
39. Piacentino V 3rd, Jones J, Fisher CA, et al. Off-pump technique for insertion of a HeartMate vented electric left ventricular assist device J Thorac Cardiovasc Surg. 2004; 127: 262-264.
40. Westaby S, Banning AP, Jarvik R, et al. First permanent implant of the Jarvik 2000 heart. Lancet. 2000; 356: 900-903.
41. Siegenthaler MP, Westaby S, Frazier OH, et al. Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J. 2005; 26:1031-1038.
42. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg. 2003; 237: 631-636.
43. Siegenthaler MP, Frazier OH, Beyersdorf F, et al. Mechanical reliability of the Jarvik 2000 heart. Ann Thorac Surg. 2006; 81: 1752-1759.
44. Sharples LD, Cafferty F, Demitis N, et al. Evaluation of the clinical effectiveness of the ventricular assist device program in the United Kingdom (EVAD UK). J Heart Lung Transplant. 2007; 26; 1: 9-15.
45. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001; 122: 1186-1195.
46. Frazier OH, Gemmato C, Myers TJ, et al. Initial clinical experience with the HeartMate® II axial-flow left ventricular assist device. Tex Heart Inst J. 2007; 34: 275-281.
47. Hoshi H, Shinshi T, Takatani S. Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs. 2006; 30: 324-338.
48. Hetzer R, Weng Y, Potapov EV, et al. First experiences with a novel magnetically suspended axial flow left ventricular assist device. Eur J Cardiothorac Surg. 2004; 25: 964-970.
49. Farrar DJ, Bourque K, Dague CP, Cotter CJ, Poirier VL. Design features, developmental status, and experimental results with the Heartmate III centrifugal left ventricular assist system with a magnetically levitated rotor. ASAIO J. 2007; 53: 310-315.
50. Pitsis AA, Visouli AN, Vassilikos V, et al. First human implantation of a new rotary blood pump: Design of the clinical feasibility study. Hellenic J Cardiol. 2006; 47: 368-376.
51. Esmore DS, Kaye D, Salamonsen R, et al. First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure. J Heart Lung Transplant. 2005; 24: 1150-1154.
52. Hon J, Yacoub M. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg. 2003; 75: S36-S41.
53. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005; 112 (9 Suppl): I32-36.
54. Liang H, Lin H, Weng Y, Dandel M, Hetzer R. Prediction of cardiac function after weaning from ventricular assist devices. J Thorac Cardiovasc Surg. 2005; 130: 1555-2156.
55. Madigan JD, Barbone A, Choudhri AF, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg. 2001; 121: 902-908.
56. Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support. A prospective multicenter study of the LVAD working group. Circulation. 2007; 115: 2497-2505.
57. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006; 355: 1873-1884.
58. Potapov EV, Loforte A, Weng Y, et al. Experience with over 1000 implanted ventricular assist devices. J Card Surg. 2008; 23: 185-194.
59. Pitsis AA, Visouli AN, Ninios V, et al. The surgical approach to reverse ventricular remodeling with the use of ventricular assist devices as bridge to recovery. Eur J Heart Fail. 2007; 6 (Suppl 1): 115.
60. Klotz S, Deng MC, Stypmann J, et al. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg. 2004; 77: 143-149; discussion 149-150.
61. Thohan V, Stetson SJ, Nagueh SF, et al. Cellular and hemodynamic responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant. 2005; 24: 566-575.
62. Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation. 2007; 116 (11 Suppl): I8-15.
63. Klotz S, Stypmann J, Welp H, et al. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant? Ann Thorac Surg. 2006; 82: 1774-1778.
64. Garcia S, Kandar F, Boyle A, et al. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading. J Heart Lung Transplant. 2008; 27: 261-267.
65. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant. 2007; 26: 815-818.
66. Potapov EV, Loebe M, Abdul-Khaliq H, et al. Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs. J Heart Lung Transplant. 2001; 20: 1310-1316.
67. Pagani FD, Long JW, Dembitsky WP, Joyce LD, Miller LW. Improved mechanical reliability of the HeartMate XVE left ventricular assist system. Ann Thorac Surg. 2006; 82: 1413-1418.
68. Gregoric ID, La Francesca S, Myers T. A less invasive approach to axial flow pump insertion. J Heart Lung Transplant. 2008; 27: 423-426.
69. Schulman AR, Martens TP, Christos PJ, et al. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. Thorac Cardiovasc Surg. 2007; 133: 841-842.
70. Sharples LD, Dyer M, Cafferty F, et al. Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). J Heart Lung Transplant. 2006; 25: 1336-1343.
71. Clegg AJ, Scott DA, Loveman E. The clinical cost-effectiveness of left ventricular assist devices for end-stage heart failure. A systematic review and economic evaluation. Health Technol Assess. 2005; 9: 1-132.
72. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant. 2005; 24; 956-967.
73. Strüber M, Lange R, Gummert JF, et al. Alternatives to heart transplantation. Symposium of the "Treatment of End-stage Heart and Lung Failure" working group on October 22, 2005 in Munich. Thorac Cardiovasc Surg. 2007; 55 (Suppl 2): S147-167.